As of Feb 26
| -0.07 / -1.17%|
The 5 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 8.50, with a high estimate of 10.00 and a low estimate of 8.00. The median estimate represents a +43.58% increase from the last price of 5.92.
The current consensus among 5 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.